Instituto de Microcirugía Ocular
Instituto de Microcirugía Ocular (IMO Grupo Miranza) is a Barcelona-headquartered network of four ophthalmology clinics in Spain and Andorra delivering diagnosis, medical treatment, and surgery across all ophthalmic subspecialties, including cornea, refractive, cataract, retina, glaucoma, and pediatric care, serving individual patients on a direct-to-consumer basis.
- Company typePrivate
- Founded1985
- HeadquartersBarcelona, Spain
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Instituto de Microcirugía Ocular does
Instituto de Microcirugía Ocular (operating as IMO Grupo Miranza) is a Barcelona-headquartered network of ophthalmology clinics providing diagnosis, medical treatment, and surgery across the full ophthalmic subspecialty spectrum, including cornea, cataract, refractive surgery, retina and vitreous, glaucoma, pediatric ophthalmology, oculoplastics, ocular surface, neuro-ophthalmology, and genetic diagnostics. Founded in the mid-1980s, the group operates four physical sites in Barcelona (flagship, with 200+ parking spaces and the group's molecular biology laboratory), Madrid (opened 2020), Manresa (opened 2020, operated via Instituto Oftalmológico Làser Visió S.L.U.), and Andorra la Vella (opened 2022, via Miranza Pirineos S.A.U.). The clinic combines a referral complex-case model with a high-volume refractive and cataract practice, performing roughly 200 corneal transplants per year (approximately 70% selective/lamellar) and using femtosecond-laser technology for refractive surgery through small-incision ReLEx SMILE.
Clinically, IMO differentiates through technology and subspecialist talent. Surgical capability is built on femtosecond and excimer lasers for refractive and cataract work, selective/lamellar corneal transplantation techniques (DMEK and related procedures), and corneal crosslinking with documented keratoconus halt rates around 95%. The in-house molecular biology and genetics laboratory, plus an AEMPS-accredited Ethics Committee for Research with Medicines (CEIm), support sponsored clinical studies and translational research into therapies for currently incurable ocular diseases. The medical team includes co-founder Dr. José Luis Güell (cornea and refractive surgery, 700+ publications) and Dr. María Teresa Iradier (2013 American Academy of Ophthalmology Achievement Award), enabling the clinic to position itself as an international reference center for combined and high-complexity ophthalmic procedures.
Commercially, IMO operates a direct-to-consumer model, accepting patients through online appointment booking, telephone, teleconsultation, and a 24/7/365 emergency ophthalmology service, complemented by partnerships with Spanish health insurers (mutuas), patient financing for non-covered procedures, and an IMO Club loyalty program. Since 2019 the group has been a member of Grupo Miranza, a Spanish network of eye-wellness excellence centers, sharing branding and digital infrastructure (miranza.es). Revenue is generated almost entirely from professional services: consultations, diagnostic tests, surgical procedures (refractive, cataract, corneal transplant, oculoplastic), with premium cataract and refractive tiers; ancillary income derives from financing, emergency services, teleconsultation, and clinical-research activity. The group consists of three Spanish/Andorran legal entities and employs between 51 and 100 staff.
Instituto de Microcirugía Ocular firmographics
Firmographics- Name
- Instituto de Microcirugía Ocular
- Legal name
- INSTITUTO DE MICROCIRUGÍA OCULAR DOS, S.L.U.
- Website
- https://imo.es
- Company type
- Private
- Founded year
- 1985
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Instituto de Microcirugía Ocular (IMO Grupo Miranza) is a Barcelona-headquartered network of four ophthalmology clinics in Spain and Andorra delivering diagnosis, medical treatment, and surgery across all ophthalmic subspecialties, including cornea, refractive, cataract, retina, glaucoma, and pediatric care, serving individual patients on a direct-to-consumer basis.
- Ownership category
- akta.pro rank
Instituto de Microcirugía Ocular industry classification
Industry- Product category
- Ophthalmology Services
- NAICS
- Offices of Optometrists (62132), Offices of Optometrists (621320), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery) (HLAKAKAO)
- akta.pro secondary industries
- Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH), Contact Lens Specialty & Myopia Control (HLAKAKAK)
Keywords
Where Instituto de Microcirugía Ocular is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices4 records
Markets served
Instituto de Microcirugía Ocular business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Ophthalmology Consultations and Medical Services: Direct patient consultations across multiple specialties including cornea, retina, glaucoma, pediatric ophthalmology, and oculoplastics. Services include diagnostic tests, medical treatments, and surgical procedures.
- Surgical Procedures: Revenue from refractive surgery (laser and intraocular lenses), cataract surgery, corneal transplants, and complex combined ophthalmological procedures. Premium services include Premium cataract surgery.
- Diagnostic Testing: Ophthalmological diagnostic tests including corneal topography, ocular response analysis, and specialized examinations for pre-surgical evaluation.
- Financing Services: Patient financing options for treatments and surgeries, allowing payment installments for procedures not covered by insurance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Insurance/mutual coverage accepted |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels6 records
Instituto de Microcirugía Ocular product offering
Product offeringCore offering
Instituto de Microcirugía Ocular (IMO) is a Spanish ophthalmology clinic chain that provides comprehensive eye care, including diagnosis, medical treatment, and surgical interventions across subspecialties such as cornea, cataract, refractive surgery, retina, glaucoma, pediatric ophthalmology, and oculoplastics. Founded in 1985 in Barcelona, the group operates four centers in Barcelona, Madrid, Andorra, and Manresa, and complements its clinical practice with an in-house molecular biology and genetics laboratory, teleconsultation, and 24-hour emergency services.
Product overview
IMO Grupo Miranza is a network of ophthalmology clinics operating across Spain (Barcelona, Madrid, Manresa) and Andorra, providing comprehensive eye care services. The offering is organized as a multi-location clinic network with specialized departments including cornea, cataract, refractive surgery, retina, glaucoma, pediatric ophthalmology, oculoplastics, and dry eye treatment. The organization operates proprietary diagnostic facilities (corneal topography), surgical theatres, and a molecular biology laboratory for research. Key treatments include laser refractive surgery (LASIK, Relex SMILE), corneal crosslinking, intrastromal rings, and corneal transplantation. Additional services include 24-hour emergencies, teleconsultation, and a patient loyalty program. The clinic chain is part of Grupo Miranza, a leader in eye health excellence centers.
Differentiator
Problem solved
Functional benefit
Products and services
- Refractive Surgery
Quantifiable outcome
- Corneal crosslinking successfully halts keratoconus progression in 95% of treated patients
- +4 more outcomes
Companies that use Instituto de Microcirugía Ocular
Customer profileSegments5 records
Ideal customer profiles1 record
Instituto de Microcirugía Ocular technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Instituto de Microcirugía Ocular partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Teatro RealminorIMO Grupo Miranza Madrid has established a partnership with Teatro Real (Royal Theater) to promote eye health and wellness to theater members. The agreement offers Teatro Real members and visitors a 10% discount on first visits, reviews, diagnostic tests, and both surgical and non-surgical treatments. This partnership aims to combine cultural engagement with health awareness, leveraging the theater's membership base to reach potential patients seeking ophthalmological services.
Scale indicators7 records
Recent moves8 records
Expansion highlights5 records
Instituto de Microcirugía Ocular competitors and assessment
Company assessmentDirect peers
- Admiravisión: Admiravisión is a Spain-based ophthalmology and refractive surgery group with a multi-site clinic model targeting similar patient segments to IMO (refractive surgery, cataract, general ophthalmology). It is a comparable direct competitor in the Spanish outpatient eye-care market.
- Clínica Baviera: Clínica Baviera is the largest ophthalmology clinic chain in Spain and Europe, operating dozens of clinics across Spain, Germany, Austria, and Italy with a similar focus on refractive surgery, cataract, and other ophthalmic subspecialties. It is the most direct comparable to IMO in business model, patient profile, and Spanish market positioning.
- Vissum (Grupo Miranza): Vissum is a Spanish ophthalmology chain owned by the same parent, Grupo Miranza, with multiple sites focused on refractive surgery and general ophthalmology. As an intra-group peer, it competes with IMO in some markets and shares capital, branding, and management infrastructure.
- Centro de Oftalmología Barraquer: Barraquer is a long-established ophthalmology center in Barcelona offering comprehensive subspecialty services including cornea, refractive, cataract, retina, and oculoplastics, with a strong research and teaching tradition. It competes head-to-head with IMO for premium complex ophthalmology cases in the Barcelona catchment.
Others
- Alcon: Alcon is a global leader in ophthalmic medical devices and pharmaceuticals, supplying IOLs, refractive surgery lasers, and surgical equipment that IMO uses in cataract and refractive procedures. While not a direct competitor, Alcon shapes the technology and pricing environment in which IMO operates.
- Carl Zeiss Meditec: Carl Zeiss Meditec manufactures ophthalmic diagnostic and surgical equipment, including lasers used in refractive surgery and optical coherence tomography systems used in diagnostics at IMO. It is an enabling supplier rather than a competitor, but influential on technology roadmaps in IMO's clinical areas.
Broad incumbents
- Moorfields Eye Hospital NHS Foundation Trust: Moorfields is one of the world's oldest and largest specialist ophthalmology hospitals, an international reference center for complex eye disease, research, and teaching. It is comparable to IMO as a benchmark for the international reference center positioning and as a potential competitor for cross-border complex cases.
Emerging players
- Hospital Universitario Virgen del Rocío (Ophthalmology Dept.): The ophthalmology department of this major Spanish public teaching hospital performs complex ocular surgery and is a recognized training and research site. It overlaps with IMO in high-complexity procedures but operates under a public funding model rather than a private-pay clinic model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Instituto de Microcirugía Ocular social profiles
Digital presenceInstituto de Microcirugía Ocular financial estimates
Financial estimateRevenue estimate
Valuation estimate
Instituto de Microcirugía Ocular leadership team
Management profileNumber of profiles
Profiles1 record
Instituto de Microcirugía Ocular subsidiaries and ownership
Company hierarchySubsidiaries1 record
Instituto de Microcirugía Ocular funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Instituto de Microcirugía Ocular M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Instituto de Microcirugía Ocular
What does Instituto de Microcirugía Ocular do?
Instituto de Microcirugía Ocular (IMO) is a Spanish ophthalmology clinic chain that provides comprehensive eye care, including diagnosis, medical treatment, and surgical interventions across subspecialties such as cornea, cataract, refractive surgery, retina, glaucoma, pediatric ophthalmology, and oculoplastics. Founded in 1985 in Barcelona, the group operates four centers in Barcelona, Madrid, Andorra, and Manresa, and complements its clinical practice with an in-house molecular biology and genetics laboratory, teleconsultation, and 24-hour emergency services.
Is Instituto de Microcirugía Ocular a public or private company?
Instituto de Microcirugía Ocular is a private company. It is classified as corporate owned and is currently operating.
When was Instituto de Microcirugía Ocular founded?
Instituto de Microcirugía Ocular was founded in 1985. It employs 51 to 100 people.
Where is Instituto de Microcirugía Ocular based?
Instituto de Microcirugía Ocular is headquartered in Barcelona, Spain, in the Europe region.
How does Instituto de Microcirugía Ocular make money?
Four revenue lines are on record. Ophthalmology Consultations and Medical Services are the primary driver. The others are surgical Procedures, diagnostic Testing and financing Services.
Who are Instituto de Microcirugía Ocular's main competitors?
Direct peers on record are Admiravisión, Clínica Baviera, Vissum (Grupo Miranza) and Centro de Oftalmología Barraquer. Others are Alcon and Carl Zeiss Meditec. Moorfields Eye Hospital NHS Foundation Trust is listed as a broad incumbent. Hospital Universitario Virgen del Rocío (Ophthalmology Dept.) is listed as an emerging player.
Does Instituto de Microcirugía Ocular have an API?
No public API is recorded for Instituto de Microcirugía Ocular.
What industry is Instituto de Microcirugía Ocular in?
Instituto de Microcirugía Ocular's product category is Ophthalmology Services. Its primary akta.pro industry code is HLAKAKAO, Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery), with a secondary code of HLAHAJAH, Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics). Its NAICS code is 62132 and its SIC code is 8011.